Congenital Syphilis Cases in Newborns Increase 32% in the US

More than 3,700 babies were born with congenital syphilis in 2022, a 32% increase from 2021. Health officials are calling for stepped-up prevention measures.

In an alarming development, the United States has witnessed a significant surge in syphilis cases among newborns. The country's health officials are now urging for intensified prevention efforts, including recommending millions of women of childbearing age and their partners to undergo testing for this sexually transmitted disease.

The Centres for Disease Control and Prevention (CDC) reported on Tuesday that over 3,700 babies were born with congenital syphilis in 2022. This number is ten times higher than what it was a decade ago and reflects a 32% increase from the previous year. Moreover, syphilis resulted in 282 stillbirths and infant deaths last year — nearly sixteen times more than those recorded in 2012. It is worth noting that over half of these congenital syphilis cases involved mothers who tested positive during pregnancy but did not receive proper treatment.

Challenges Faced by Healthcare Providers

The rise in congenital syphilis cases comes despite repeated warnings by public health agencies, tying it to an upsurge in primary and secondary adult syphilis cases. Additionally, healthcare providers have been struggling to obtain benzathine penicillin injections — the primary medical weapon against congenital syphilis — due to supply shortages.

CDC Calls for Exceptional Measures

"It is clear that something is not working here; something has to change," said Dr Laura Bachmann from CDC. "That's why we're calling for exceptional measures to address this heartbreaking epidemic." The federal agency recommends initiating treatment as soon as a pregnant woman tests positive without waiting for confirmatory testing. It also advocates expanding access to transportation so women can get treatment promptly.

Federal Recommendations Lack Financial Support

Despite the CDC's recommendations, no new federal funds are being allocated to state and local health departments to enhance testing or access. Some state health departments have already expressed that they are stretched thin when it comes to treatment and prevention.

The Silent Infection

Syphilis is a bacterial infection that was once a common but dreaded sexually transmitted disease. New infections declined in the US from the 1940s when antibiotics became widely available, reaching their lowest point in the late 1990s. However, by 2002, cases started rising again.

Impact of Syphilis on Pregnant Women and Newborns

In congenital syphilis cases, mothers pass on the disease to their babies which could lead to child death or severe health issues like deafness, blindness and malformed bones. Poor access to prenatal care can make this difficult as nearly 40% of last year's congenital syphilis cases involved mothers who didn't receive prenatal care.

Treatment Challenges

If diagnosed early during pregnancy, a single penicillin shot can prevent transmission of syphilis from mother to baby. However, later stages require multiple shots completed at least 30 days before delivery. Furthermore, shortage of these injections pose significant challenges in reducing syphilis numbers.

Pfizer’s Penicillin Shortage

Pfizer is currently the sole supplier of penicillin shots in America. Earlier this year company officials announced supply shortages due to increased demand with resolution not expected until next year.

In conclusion, while steps are being taken towards diagnosing and treating syphilis among pregnant women more effectively; lack of resources including medical supplies and financial support continue to pose serious challenges for healthcare providers across America trying desperately to tackle this growing epidemic. It is crucial for government and health agencies to collaborate and devise comprehensive strategies to ensure better access to testing, treatment and prevention measures.